Exicure (XCUR) Common Equity (2016 - 2026)
Exicure (XCUR) reported Common Equity of $2.1 million for Q1 2026, down 81.57% on a YoY basis from $11.4 million in Q1 2025, and down 46.56% quarter-over-quarter from $3.9 million in Q4 2025.
Exicure (XCUR) Common Equity (2016 - 2026) Analysis & Trends
Exicure has reported Common Equity for 11 years, with the latest figure at $2.1 million in Q1 2026.
- For the quarter ending Q1 2026, Common Equity fell 81.57% year-over-year to $2.1 million; the trailing twelve-month figure through Mar 2026 stood at $2.1 million (down 81.57% YoY), and the FY2025 full-year result was $3.9 million, down 42.03% from the prior year.
- Common Equity for Q1 2026 stood at $2.1 million, down from $3.9 million in the prior quarter.
- The five-year high for Common Equity was $14.9 million in Q4 2022, with the low at -$3.7 million in Q3 2022.
- Historically, Common Equity has averaged $5.5 million across 5 years, with a median of $3.9 million in 2025.
- Annual changes were most pronounced in 2022 — Common Equity plunged 126.48% — and 2023, when it soared 734.48%.
- Exicure's Common Equity stood at $14.9 million in 2022, then sank by 79.69% to $3.0 million in 2023, then soared by 123.42% to $6.8 million in 2024, then sank by 42.03% to $3.9 million in 2025, then sank by 46.56% to $2.1 million in 2026.
- The last three Common Equity figures came in at $2.1 million (Q1 2026), $3.9 million (Q4 2025), and $6.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 35.63 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -1.42 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 14.38 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | 13.21 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 11.87 Mn |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 19.36 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | - |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 2.10 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.10 Mn |
| Dec 31, 2025 | 3.93 Mn |
| Sep 30, 2025 | 6.93 Mn |
| Jun 30, 2025 | 8.86 Mn |
| Mar 31, 2025 | 11.38 Mn |
| Dec 31, 2024 | 6.77 Mn |
| Sep 30, 2024 | 1.55 Mn |
| Jun 30, 2024 | 1.61 Mn |
| Mar 31, 2024 | 2.21 Mn |
| Dec 31, 2023 | 3.03 Mn |
| Sep 30, 2023 | 4.50 Mn |
| Jun 30, 2023 | 9.71 Mn |
| Mar 31, 2023 | 14.62 Mn |
| Dec 31, 2022 | 14.92 Mn |
| Sep 30, 2022 | -3.70 Mn |
| Jun 30, 2022 | 1.16 Mn |
| Mar 31, 2022 | 3.24 Mn |
| Dec 31, 2021 | 11.23 Mn |
| Sep 30, 2021 | 13.98 Mn |
| Jun 30, 2021 | 36.64 Mn |